As a science-driven biotech, we have always worked closely with a variety of stakeholders in the scientific and healthcare sector. These relationships and partnerships are invaluable to Galapagos. We are proud of our collaborative spirit and will remain transparent about our research and business practices to our stakeholders. We believe that transparency is vital to strengthen the basis for future collaboration.
Under the applicable legislation and self-regulation codes, we disclose payments made to Healthcare Professionals, Healthcare Organizations and Patient Organizations, such as fee for services, support for events, grants and donations.
We publish Transfers of Value (ToV) made to these stakeholders in our markets across Europe. You can consult the Transfers of Values made in the reporting section below. Where there is a local platform in place, we encourage its usage and link to it. Our Methodology Note describes our commitment, our processes and the definitions of the ToV categories.
2023 Transactions, published in 2024
2022 Transactions, published in 2023
2023 Transactions, published in 2024
2022 Transactions, published in 2023
2023 Transactions, published in 2024
2022 Transactions, published in 2023
2021 Transactions, published in 2022
2020 Transactions, published in 2021
2023 Transactions, published in 2024
2022 Transactions, published in 2023
2021 Transactions, published in 2022
R&D transfers of values to Dutch HCPs/HCOs
2023 Transactions, published in 2024
2022 Transactions, published in 2023
2023 Transactions, published in 2024
2022 Transactions, published in 2023
2021 Transactions, published in 2022
2020 Transactions, published in 2021
2023 Transactions, published in 2024
2022 Transactions, published in 2023
For Patient Organisations, Public, Patients and Journalists
For HCP / HCO